Table 1.
Patient and biopsy characteristics
| Age | Sex | History | Days on ECMO prior to biopsy |
Systemic anticoagulation prior to biopsy |
Procedure | Pathology | Impact on Management |
Transfusions during the 5 days prior to biopsy (units) |
Transfusions during the 3 days following biopsy (units) |
New PTX following procedure |
Survival to hospital discharge |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | F | DAH without known autoimmune disease | 2 | No | VATS | DAD without capillaritis | Cytotoxic therapy withheld | 2 | 3 | No | No |
| 66 | M | ARDS following HSCT | 23 | Yes | Tbbx with cup forceps | Organizing pneumonia | None (Continued on steroids) |
3 | 1 | No | No |
| 66 | F | ARDS, concern for rapidly progressive ILD | 1 | No | Cryobiopsy | DAD | None | 2 | 4 | No | No |
| 78 | M | ARDS with CMV viremia | 10 | No | Tbbx with cup forceps | DAD, no CMV seen | None | 3 | 0 | No | No |
| 32* | F | Lung transplant recipient with ARDS and CMV viremia | 20 | No | Tbbx with cup forceps | DAD, no acute rejection, + CMV inclusions | Immunosuppressive medication reduced, continued on antiviral therapy | 3 | 1 | No | No |
| 32* | F | Lung transplant recipient with ARDS and CMV viremia | 50 | Yes | Tbbx with cup forceps | Scant lung parenchyma with chronic inflammation. No CMV | None | 4 | 6 | No | No |
| 43 | F | ARDS & Influenza A (H1N1) | 10 | Yes | Wedge resection during emergent thoracotomy for hemothorax | DAD, negative infectious stains | None | 11 | 3 | No | Yes |
| 56 | F | ARDS and Influenza A | 3 | Yes | Cryobiopsy | DAD and organizing pneumonia | None (Continued on steroids) |
3 | 0 | No | Yes |
| 19 | F | ARDS & disseminated adenovirus | 11 | Yes | Mini-thoracotomy | DAD and organizing pneumonia, necrotizing candida lusitaniae pneumonia | None (Continued on micafungin) |
5 | 8 | No | No |
| 62 | M | ARDS | 13 | No | Wedge resection during exploratory thoracotomy for intrathoracic hematoma evacuation | Chronic inflammation with areas of organization | None | 13 | 8 | No | No |
Abbreviations: ARDS, acute respiratory distress syndrome; CMV, cytomegalovirus; DAD, diffuse alveolar damage; DAH, diffuse alveolar hemorrhage; ECMO, extracorporeal membrane oxygenation; HSCT, hematopoietic stem cell transplant; ILD, interstitial lung disease; F, female; M, male; Pt, patient; PTX, pneumothorax; Tbbx, transbronchial biopsy; VATS, video-assisted thoracoscopic surgery
Patient underwent two separate lung biopsy procedures